Climara
Description
Clinical
Indications
Side Effects
Warnings
OverDosage
Patient Info


PATIENT INFORMATION


PATIENT PACKAGE INSERT

Vaginal Cream, Oral Tablets, and Transdermal System

This information describes when and how to use estrogens, and the risks and benefits of estrogen treatment.

Estrogens have important benefits but also some risks. You must decide, with your doctor, whether the risks to you of estrogen use are acceptable because of their benefits. If you use estrogens, check with your doctor to be sure you are using the lowest possible dose that works, and that you don't use them longer than necessary. How long you need to use estrogens will depend on the reason for use.

Additional Information for the Climara System: The Climara system that your doctor has prescribed for you releases small amounts of estradiol through the skin in a continuous way. Estradiol is the same hormone that your ovaries produce abundantly before menopause. The dose of estradiol you require will depend upon your individual response. The dose is adjusted by the size of the Climara system used: the systems are avaialble in 4 sizes.

Additional Information for Vaginal Cream: NOTE: The number of doses per tube of estradiol vaginal cream will vary with dosage requirements and patient handling.

Vaginal Cream and Oral Tablets:

1. Estrogens Increase the Risk of Cancer of the Uterus in Women Who Have Had Their Menopause ("Change Of Life"): If you are using any estrogen-containing drug, it is important to visit your doctor regularly and report any unusual vaginal bleeding right away. Vaginal bleeding after menopause may be a warning sign of uterine cancer. Your doctor should evaluate any unusual vaginal bleeding to find out the cause.

2. Estrogens Should not be Used During Pregnancy: Estrogens do not prevent miscarriage (spontaneous abortion) and are not needed in the days following childbirth. If you take estrogens during pregnancy, your unborn child has a greater than usual chance of having birth defects. The risk of developing these defects is small, but clearly larger than the risk in children whose mothers did not take estrogens during pregnancy. These birth defects may affect the baby's urinary system and sex organs. Daughters born to mothers who took DES (an estrogen drug) have a higher than usual chance of developing cancer of the vagina or cervix when they become teenagers or young adults. Sons may have a higher than usual chance of developing cancer of the testicles when they become teenagers or young adults.


Information About Climara

How the Cliamara System Works: The Climara system contains 17b-estradiol. When applied to the skin as directed below, the Climara system releases 17b-estradiol, which flows through the skin into the bloodstream.

How and Where to Apply the Climara System: Each Climara system is individually sealed in a protective pouch. To open the pouch, hold it vertically with the Climara name facing you. Tear left to right using the top tear notch. Tear from bottom to top using the side tear notch. Pull the pouch open. The Climara patch is the translucent plastic film attached to the clear, thicker plastic backing. There is a silver-foil sticker securely attached to the inside of the pouch. This contains a moisture protectant (desiccant). Do not remove it. Carefully remove the Climara patch. You'll notice that the patch is attached to a thicker, hard-plastic backing and that the patch itself is oval and transparent.

Apply the adhesive side of the Climara system to a clean, dry area of the lower abdomen or the upper quadrant of the buttock. Do not apply the Climara system to your breasts. The sites of application must be rotated, with an interval of at least 1 week allowed between applications to a particular site. The area selected should not be oily, damaged, or irritated. Avoid the waistline, since tight clothing may rub and remove the system. Application to areas where sitting would would dislodge the system should also be avoided. Apply the system immediately after opening the pouch and removing the protective liner. Press the system firmly in place with the fingers for about 10 seconds, making sure there is good contact, especially around the edges.

The Climara system should be worn continuously for one week. You may wish to experiment with different locations when applying a new system, to find ones that are most comfortable for you and where clothing will not rub on the system.

When to Apply the Climara System: The Climara system should be changed once weekly.

When changing the system, remove the used Climara system and discard it. Any adhesive that might remain on your skin can easily be rubbed off. Then place the new Climara system on a different skin site. (The same skin site should not be used again for at least one week after removal of the system.)

Contact with water when you are bathing, swimming or showering, may affect the system. In the unlikely event that a system should fall off, a new system should be applied for the remainder of the 7-day dosing interval.

Vaginal Cream, Oral Tablets, and Transdermal System

Uses of Estrogen

Not every estrogen drug is approved for every use listed in this section. If you want to know which of these possible uses are approved for the medicine prescribed for you, ask your doctor or pharmacist to wshow you the product information. Generic drugs carry virtually the same labeling information as their name brand versions.

To Reduce Moderate or Severe Menopausal Symptoms: Estrogens are hormones made by the ovaries of normal women. Between ages 45 and 55, the ovaries normally stop making estrogens. This leads to a drop in body estrogen levels which causes the "change of life" or menopause (the end of monthly menstrual periods). If both ovaries are removed during an operation before natural menopause takes place, the sudden drop in estrogen levels causes "surgical menopause."

When the estrogen levels begin dropping, some women develop very uncomfortable symptoms, such as feelings of warmth in the face, neck and chest, or sudden intense episodes of heat and sweating ("hot flashes or "hot flushes"). Using estrogen drugs can help the body adjust to lower estrogen levels and reduce these symptoms. Most women have only mild menopausal symptoms or none at all and do not need to use estrogen drugs for these symptoms. Others may need to take estrogens for a few months while their bodies adjust to lower estrogen levels. The majority of women do not need estrogen replacement for longer than 6 months for these symptoms.

To Treat Vulval and Vaginal Atrophy: (Itching, burning, dryness in or around the vagina, difficulty or burning on urination) associated with menopause.

To treat certain conditions in which a young woman's ovaries do not produce enough estrogen naturally.

To treat certain types of abnormal vaginal bleeding due to hormonal imbalance when your doctor has found no serious cause of the bleeding.

To treat certain cancers in special situations, in men and women.

To Prevent Thinning of Bones: Osteoporosis is a thinning of the bones that makes them weaker and allows them to break more easily. The bones of the spine, wrists and hips break most often in osteoporosis. Both men and women start to lose bone mass after about age 40, but women lose bone mass faster after the menopause. Using estrogens after the menopause slows down bone thinning and may prevent bones from breaking. Lifelong adequate calcium intake, either in the diet (such as dairy products) or by calcium supplements (to reach a total daily intake of 1000 milligrams per day before menopause or 1500 milligrams per day after menopause), may help to prevent osteoporosis. Regular weight-bearing exercise (like walking and running for an hour, two or three times a week) may also help to prevent osteoporosis. Before you change your calcium intake or exercise habits, it is important to discuss these lifestyle changes with your doctor to find out if they are safe for you.

Since estrogen use has some risks, only women who are likely to develop osteoporosis should use estrogens for prevention. Women who are likely to develop osteoporosis often have the following characteristics: White or Asian race, slim, cigarette smokers, and a family history of osteoporosis in a mother, sister, or aunt. Women who have relatively early menopause, often because their ovaries were removed during an operation ("surgical menopause") are more likely to develop osteoporosis than women whose menopause happens at the average age.

Who Should Not Use Estrogens

Estrogens should not be used:
  • During Pregnancy: See BOXED WARNING, Vaginal Cream; BOXED WARNING, Oral Tablets; or BOXED WARNING, Transdermal. If you think you may be pregnant, do not use any form of estrogen-containing drug. Using estrogens while you are pregnant may cause your unborn child to have birth defects. Estrogens do not prevent miscarriage.
  • If You Have Unusual Vaginal Bleeding Which Has not Been Evaluated by Your Doctor: See BOXED WARNING, Vaginal Cream; BOXED WARNING, Oral Tablets; or BOXED WARNING, Transdermal. Unusual vaginal bleeding can be a warning sign of cancer of the uterus, especially if it happens after menopause. Your doctor must find out the cause of the bleeding so that he or she can recommend the proper treatment. Taking estrogens without visiting your doctor can cause you serious harm if your vaginal bleeding is caused by cancer of the uterus.
  • If You Have Had Cancer: Since estrogens increase the risk of certain types of cancer, you should not use estrogens if you have ever had cancer of the breast or uterus, unless your doctor recommends that the drug may help in cancer treatment. (For certain patients with breast or prostate cancer, estrogens may help.)
  • If You Have any Circulation Problems: Estrogen drugs should not be used except in unusually special situations in which your doctor judges that you need estrogen therapy so much that the risks are acceptable. Men and women with abnormal blood clotting conditions should avoid estrogen use (see Dangers of Estrogens).
  • When They do not Work: During menopause, some women develop nervous symptoms or depression. Estrogens do not relieve these symptoms. You may have heard that taking estrogens for years after menopause will keep your skin soft and supple and keep you feeling young. There is no evidence for these claims and such long-term estrogen use may have serious risks.
  • After Childbirth or When Breastfeeding a Baby: Estrogens should not be used to try to stop the breasts from filling with milk after a baby is born. Such treatment may increase the risk of developing blood clots (see Dangers of Estrogens).

If you are breastfeeding, you should avoid using any drugs because many drugs pass through to the baby in the milk. While nursing a baby, you should take drugs only on the advice of your health care provider.

Dangers of Estrogens

Cancer of the Uterus: Your risk of developing cancer of the uterus gets higher the longer you use estrogens and the larger doses you use. One study showed that after women stop taking estrogens, this higher cancer risk quickly returns to the usual level of risk (as if you had never used estrogen therapy). Three other studies showed that the cancer risk stayed high for 8 to more than 15 years after stopping estrogen treatment. Because of this risk, IT IS IMPORTANT TO TAKE THE LOWEST DOSE THAT WORKS AND TO TAKE IT ONLY AS LONG AS YOU NEED IT.

Using progestin therapy together with estrogen therapy may reduce the higher risk of uterine cancer related to estrogen use (but see Other Information).

If you have had your uterus removed (total hysterectomy), there is no danger of developing cancer of the uterus.

Cancer of the Breast: Most studies have not shown a higher risk of breast cancer in women who have ever used estrogens. However, some studies have reported that breast cancer developed more often (up to twice the usual rate) in women who used estrogens for long periods of time (especially more than 10 years), or who used higher doses for shorter time periods.

Regular breast examinations by a health professional and monthly self-examination are recommended for all women.

Gallbladder Disease: Women who use estrogens after menopause are more likely to develop gallbladder disease needing surgery than women who do not use estrogens.

Abnormal Blood Clotting: Taking estrogens may cause changes in your blood clotting system. These changes allow the blood to clot more easily, possibly allowing clots to form in your bloodstream. If blood clots do form in your bloodstream, they can cut off the blood supply to vital organs, causing serious problems. These problems may include a stroke (by cutting off blood to the brain), a heart attack (by cutting off blood to the heart), a pulmonary embolus (by cutting off blood to the lungs), or other problems. Any of these conditions may cause death or serious long term disability. However, most studies of low dose estrogen usage by women do not wshow an increased risk of these complications.

Side Effects

In addition to th
  • Nausea and vomiting.
  • Breast tenderness or enlargement.
  • Enlargement of benign tumors ("fibroids") of the uterus.
  • Retention of excess fluid. This may make some conditions worsen, such as asthma, epilepsy, migraine, heart disease, or kidney disease.
  • A spotty darkening of the skin, particularly of the face.

Reducing Risk of Estrogen Use

If you use estrogens, you can reduce your risks by doing these things:

See Your Doctor Regularly: While you are using estrogens, it is important to visit your doctor at least once a year for a check-up. If you develop vaginal bleeding while taking estrogens, you may need further evaluation. If members of your family have had breast cancer or if you have ever had breast lumps or an abnormal mammogram (breast x-ray), you may need to have more frequent breast examinations.

Reassess Your Need for Estrogens: You and your doctor should reevaluate whether or not you still need estrogens at least every six months.

Be Alert for Signs of Trouble: If any of these warning signals (or any other unusual symptoms) happen while you are using estrogens, call your doctor immediately:
  • Abnormal bleeding from the vagina (possible uterine cancer).
  • Pains in the calves or chest, sudden shortness of breath, or coughing blood (possible clot in the legs, heart or lungs).
  • Severe headache or vomiting, dizziness, faintness, changes in vision or speech, weakness or numbness of an arm or leg (possible clot in the brain or eye).
  • Breast lumps (possible breast cancer; ask your doctor or health professional to wshow you how to examine your breasts monthly).
  • Yellowing of the skin or eyes (possible liver problem).
  • Pain, swelling, or tenderness in the abdomen (possible gallbladder problem).

Other Information

Your doctor has prescribed this drug for you and you alone. Do not give the drug to anyone else.

If you will be taking calcium supplements as party of the treatment to help prevent osteoporosis, check with your doctor about how much to take.

Keep this and all drugs out of the reach of children. In case of overdose, call your doctor, hospital or poison control center immediately.

Vaginal Cream and Oral Tablets

Some doctors may choose to prescribe a progestin, a different hormonal drug, for you to take together with your estrogen treatment. Progestins lower your risk of developing endometrial hyperplasia (a possible pre-cancerous condition of the uterus) while using estrogens. Taking estrogens and progestins together may also protect you from the higher risk of uterine cancer, but this has not been clearly established. Combined use of progestin and estrogen treatment may have additional risks, however, the possible risks include unhealthy effects on blood fats (especially a lowering of HDL cholesterol, the “good” blood fat which protects against heart disease risk), unhealthy effects on blood sugar (which might worsen a diabetic condition), and a possible further increase in the breast cancer risk which may be associated with long-term estrogen use. The type of progestin drug used and its dosage schedule may be important in minimizing these effects.

Transdermal System

Estrogens increase the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, with estrogen lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctors may prescribe a progestin for you to take together with your estrogen.

You should know, however, that taking estrogens with progestins may have additional risks. These include: Unhealthy effects on blood fats (especially a lowering of HDL blood cholestrol, the "good" blood fat which protects against heart disease); unhealthy effects on blood sugar (which might make a diabetic condition worse); and a possible further increase in breast cancer risk which may be associated with long term estrogen use.

Some research has shown that estrogens taken without progestins may protect women against developing heart disease. However, this is not certain. The protection shown may have been caused by the characteristics of the estrogen-treated women, and not by the estrogen treatment itself. In general, treated women were slimmer, more physically active, and were less likely to have diabetes than the untreated women. These characteristics are known to protect against heart disease.

You are cautioned to discuss very carefully with your doctor or health care provider, all the possible risks and benefits of long-term estrogen and progestin treatment as they affect you personally.

Do not store above 86°F (30°C). Do not store unpouched. Apply immediately upon removal from the protective pouch.

Vaginal Ring

Introduction

This information describes when and how to use Estring vaginal ring, and the risks and benefits of estrogen treatment. Please read this information carefully before starting treatment.

Estrogens have important benefits but also some risks. You must decide, with your doctor, whether the risks to you of estrogen use are acceptable because of their benefits. If you use estrogens, check with your doctor to be sure you are using the dose that is appropriate for you, and that you don't use them longer than necessary. How long you need to use estrogens should be decided by you and your doctor.

1. Estrogens Increase the Risk of Cancer of the Uterus in Women Who Have Had Their Menopause (“Change of Life”): If you use any estrogen-containing drug, it is important to visit your doctor regularly and report any unusual vaginal bleeding right away. Vaginal bleeding after menopause may be a warning sign of uterine cancer. Your doctor should evaluate any unusual vaginal bleeding to find out the cause.

2. Estrogens Should Not be Used During Pregnancy:Estrogens do not prevent miscarriage (spontaneous abortion) and are not needed in the days following childbirth. If you take estrogens during pregnancy, your unborn child has a greater than usual chance of having birth defects. The risk of developing these defects is small, but clearly larger than the risk in children whose mothers did not take estrogens during pregnancy. These birth defects may affect the baby's urinary system and sex organs. Daughters born to mothers who took DES (an estrogen drug) have a higher than usual chance of developing cancer of the vagina or cervix when they become teenagers or young adults. Sons may have a higher than usual chance of developing cancer of the testicles when they become teenagers or young adults.



Uses of Estrogen

Estrogens are hormones made by the ovaries of women during their reproductive years. Between ages 45 and 55, the ovaries normally stop making estrogens. This leads to a drop in body estrogen levels which causes the “change of life” or menopause (the end of monthly menstrual periods). If both ovaries are removed during an operation before natural menopause takes place, the sudden drop in estrogen levels results in what is known as “surgically induced menopause”.

When the estrogen levels begin dropping, some women develop very uncomfortable symptoms, such as feelings of warmth in the face, neck, and chest, or sudden intense episodes of heat and sweating (“hot flashes” or “hot flushes”). Using estrogen drugs can help the body adjust to lower estrogen levels and reduce these symptoms. ESTRING DOES NOT PROVIDE ENOUGH ESTROGEN TO REDUCE THESE SYMPTOMS.

The declining estrogen levels associated with advancing age after menopause may also result in thinning and drying of the tissue in the urinary tract and vagina (urogenital atrophy). Vaginal symptoms of this condition include dryness in the vagina (atrophic vaginitis), genital itching and burning, and pain with intercourse. Urinary symptoms may include urinary urgency and pain on urination. Small amounts of estrogen delivered directly to the local tissue can be used to help reduce these symptoms.

Use of Estring Vaginal Ring

Estring is a local estrogen therapy designed to relieve vaginal and urinary symptoms of postmenopausal estrogen deficiency for a full 90 days. Estring exerts its effect locally in the lower urogenital tract and has not been shown to have significant effects in other estrogen-sensitive organs or tissues of the body. Consequently, ESTRING VAGINAL RING PROVIDES RELIEF OF LOCAL SYMPTOMS OF MENOPAUSE ONLY.

Description

Estring contains a drug reservoir of 2 mg of the estrogen, estradiol, in its core. Estring releases estradiol into the vagina in a consistent, stable manner for 90 days. The soft, flexible ring is placed in the upper third of the vagina (by the physician or the patient) and worn continuously for 90 days, then removed and replaced if continuation of therapy is indicated.

Who Should Not Use Estring

Estring Should Not Be Used:

During pregnancy. See BOXED WARNING. Women who are definitely postmenopausal cannot become pregnant. Women who believe they are postmenopausal because their menstrual cycles have recently stopped should confirm that they are not pregnant before using any form of estrogen-containing drug. Using estrogens while pregnant may cause the unborn child to have birth defects. Estrogens do not prevent miscarriage.

In the presence of unusual vaginal bleeding which has not been evaluated by a doctor. See BOXED WARNING. Unusual vaginal bleeding after menopause can be a warning sign of cancer of the uterus. Estrogens may increase the risk of cancer of the uterus in women who have had their menopause (“change of life”). If you use any estrogen-containing drug, it is important to visit your doctor regularly and report any unusual vaginal bleeding right away. Your doctor should evaluate any unusual vaginal bleeding to find out the cause.

If there is a history of certain types of cancer. Estrogens may increase the risk of certain types of cancer. In general, Estring should not be used in women who have ever had cancer of the breast or uterus.

During treatment for vaginal infection with vaginal antimicrobial therapy. It is recommended that Estring be discontinued while other vaginal medications are being used to treat a vaginal infection. Use of Estring can be resumed after termination of the other vaginal medication, and after first consulting with a physician.

After childbirth or when breastfeeding a baby. Estring should not be used to try to stop the breasts from filling with milk after a baby is born. Women who are breast-feeding should avoid using any drugs because many drugs pass through to the baby in the milk. While nursing a baby, drugs should only be taken on the advice of your healthcare giver.

Possible Risks From Treatment With Estrogens

The Following Risk Factors Apply to Estrogens in General:

Cancer of the uterus. Estrogens increase the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus (endometrial cancer). The risk of endometrial cancer is greater in estrogen users than nonusers. Studies have shown that this increased risk depends on estrogen dose, duration of treatment, and treatment regimen. If the uterus has been removed (total hysterectomy), there is no danger of developing cancer of the uterus.

Cancer of the breast. Most studies have not shown a higher risk of breast cancer in women who have ever used estrogens. However, some studies have reported that breast cancer developed more often (up to twice the usual rate) in women who used estrogens for long periods of time (especially more than 10 years), or who used higher doses for shorter time periods. Regular breast examinations by a health professional and monthly self-examination are recommended for all women.

Gallbladder disease and abnormal blood clotting. Gallbladder disease and abnormal blood clotting are risk factors associated with medium to high doses of estrogen. Most studies of low dose estrogen usage by women do not wshow an increased risk of these complications, and to date have not been seen with Estring treatment.

Side Effects

Like all medications, Estring may cause side effects. The most frequently reported side effect is increased vaginal secretions. Many of these vaginal secretions are like those that occur normally prior to menopause and indicate that Estring is working. Vaginal secretions that are associated with a bad odor, vaginal itching, or other signs of vaginal infection are NOT normal and may indicate a risk or a cause for concern. Other side effects may include vaginal discomfort, abdominal pain, or genital itching.

Estrogens in General

In Addition to the Risks Listed Above, the Following Side Effects Have Been Reported With Estrogen Use:
  • Nausea and vomiting.
  • Breast tenderness or enlargement.
  • Enlargement of benign tumors (“fibroids”) of the uterus.
  • Retention of excess fluid. This may worsen some conditions, such as asthma, epilepsy, migraine, heart disease, or kidney disease.
  • Spotty darkening of the skin, particularly on the face.
Reducing Risk of Estrogen Use

If You Use Estrogens, You May Reduce Your Risks By Doing These Things:

See Your Doctor Regularly: While you are using estrogens, it is important to visit your doctor at least once a year for a check-up. If you develop vaginal bleeding while taking estrogens, call your doctor¾you may need further evaluation. If members of your family have had breast cancer or if you have ever had breast lumps or an abnormal mammogram (breast X-ray), you may need to have more frequent breast examinations.

Reassess Your Need for Estrogens: You and your doctor should reevaluate whether or not you still need estrogens at least every 6 months.

Be Alert for Warning Signs: If any of these warning signals (or any other unusual symptoms) happen while you are using estrogens, call your doctor immediately:
  • Abnormal bleeding from the vagina (possible uterine cancer).
  • Pains in the calves or chest, sudden shortness of breath, or coughing blood (possible clot in the legs, heart, or lungs).
  • Severe headache or vomiting, dizziness, faintness, changes in vision or speech, weakness or numbness of an arm or leg (possible clot in the brain or eye).
  • Breast lumps (possible breast cancer; ask your doctor or health professional to wshow you how to examine your breasts monthly).
  • Yellowing of skin or eyes (possible liver problem).
  • Pain, swelling, or tenderness in the abdomen (possible gallbladder problem).
Other Information

Estrogens increase the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Progestin, another hormone drug, is usually prescribed with higher-dose estrogen preparations to lower the risk of developing endometrial hyperplasia. Progestins are not usually needed for women using Estring alone.

Some women have experienced moving or sliding of Estring within the vagina. If this happens, Estring can be gently pushed back into position with a clean finger. Instances of Estring slipping out of the vagina have been infrequent and were usually associated with moving the bowels, straining, or constipation within the first few weeks of treatment. If this occurs, Estring can be washed with lukewarm (NOT hot) water and reinserted. If this happens repeatedly, you should consult with your doctor or healthcare giver and determine whether continued treatment is appropriate for you.

Estring may not be suitable for women with narrow, short, or stenosed (constricted) vaginas. A narrow vagina, vaginal stenosis (constriction), significant prolapse, and vaginal infections are conditions that make the vagina more susceptible to irritation or ulceration caused by Estring. Women with signs or symptoms of vaginal irritation should alert their doctor or healthcare giver.

Vaginal infection is generally more common in postmenopausal women. Vaginal infections should be treated with appropriate antimicrobial therapy before initiation of Estring. If a vaginal infection develops during use of Estring, then Estring should be removed and reinserted only after the infection has been appropriately treated. See your doctor or healthcare giver if you have vaginal discomfort or suspect you have a vaginal infection.

Your doctor has prescribed this drug for you and you alone. Do not give the drug to anyone else.

Keep this and all drugs out of the reach of children.

How Supplied

Storage: Store at controlled room temperature 15-30° C (59-86° F).

Estring Insertion

Estring can be inserted and removed by you or your doctor. To insert Estring yourself, choose the position that is most comfortable for you: standing with one leg up, squatting, or lying down.

1. After washing and drying your hands, remove Estring from its pouch using the tear-off notch on the side. (Since the ring becomes slippery when wet, be sure your hands are dry before handling it.)

2. Hold Estring between your thumb and index finger and press the opposite sides of the ring together as shown.

3. Gently push the compressed ring into your vagina as far as you can.

Estring Placement

The exact position of Estring is not critical, as long as it is placed in the upper third of the vagina.

When Estring is in place, you should not feel anything. If you feel uncomfortable, Estring is probably not far enough inside. Use your finger to gently push Estring further into your vagina.

There is no danger of Estring being pushed too far up in the vagina or getting lost. Estring can only be inserted as far as the end of the vagina, where the cervix (the narrow, lower end of the uterus) will block Estring from going any further.

Estring Use

Once inserted, Estring should remain in place in the vagina for 90 days.

Most women and their partners experience no discomfort with Estring in place during intercourse, so it is NOT necessary that the ring be removed. If Estring should cause you or your partner any discomfort, you may remove it prior to intercourse (see Estring Removal). Be sure to reinsert Estring as soon as possible afterwards.

Estring may slide down into the lower party of the vagina as a result of the abdominal pressure or straining that sometimes accompanies constipation. If this should happen, gently guide Estring back into place with your finger.

There have been rare reports of Estring falling out in some women following intense straining or coughing. If this should occur, simply wash Estring with lukewarm (NOT hot) water and reinsert it.

Estring Drug Delivery

Once in the vagina, Estring begins to release Estring immediately. Estring will continue to release a low, continuous dose of estradiol for the full 90 days it remains in place.

It will take about 2 to 3 weeks to restore the tissue of the vagina and urinary tract to a healthier condition and to feel the full effect of Estring in relieving vaginal and urinary symptoms. If your symptoms persist for more than a few weeks after beginning Estring therapy, contact your doctor.

One of the most frequently reported effects associated with the use of Estring is an increase in vaginal secretions. These secretions are like those that occur normally prior to menopause and indicate that Estring is working. However, if the secretions are associated with a bad odor or vaginal itching or discomfort, be sure to contact your doctor.

Estring Removal

After 90 days there will no longer be enough estradiol in the ring to maintain its full effect in relieving your vaginal or urinary symptoms. Estring should be removed at that time and replaced with a new Estring, if your doctor determines that you need to continue your therapy.

To remove Estring:

1. Wash and dry your hands thoroughly.

2. Assume a comfortable position, either standing with one leg up, squatting, or lying down.

3. Loop your finger through the ring and gently pull it out.

4. Discard the used ring in a waste receptacle. (Do not flush Estring).

If you have any additional questions about removing Estring, contact your doctor or healthcare giver.
Buy
Climara Now
 
Buy
Climara Now